Epigenomics AG Pursuing Development of Tamoxifen Response Test
January 30, 2006 02:41 ET
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Roche...
MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies
January 10, 2006 02:08 ET
|
MorphoSys AG
MARTINSRIED, Germany, Jan. 10, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) and Chemicon International, Inc., a subsidiary of Serologicals Corporation (Nasdaq:SERO)...